Rare Disease Diagnosis: A Focus on the Hospital da Criança de Brasília
The path to diagnosis can be long and arduous for families facing rare diseases. For Jakeline Carvalho, mother of Júlia Bonfim, this journey involved navigating initial misdiagnoses and seeking specialized care. This story highlights the challenges faced by many and the critical role of centers like the Hospital da Criança de Brasília José Alencar (HCB) in providing accurate diagnoses and treatment for rare conditions.
Understanding Rare Diseases
The World Health Organization (WHO) and the Ministry of Health define a rare disease as one that affects up to 65 people per 100,000 individuals. It is estimated that approximately 13 million Brazilians live with one of over 8,000 cataloged rare diseases. These conditions are often genetic in origin, with around 80% having a genetic component. A significant proportion of cases – 75% – manifest in childhood, and the diagnostic process can take, on average, four to five years.
The Hospital da Criança de Brasília: A National Reference
The Hospital da Criança de Brasília José Alencar (HCB) has established itself as a highly complex health unit and a national reference in the care of children with rare and complex diseases, including childhood cancer, spinal muscular atrophy (SMA), and cystic fibrosis. The hospital plays a vital role in offering accurate diagnostics and specialized treatment to thousands of patients.
The Case of Júlia Bonfim and Langerhans Cell Histiocytosis (LCH)
Júlia Bonfim, a 10-month-old, was diagnosed with Langerhans cell histiocytosis (LCH), a rare disease affecting approximately 8.9 per million children under 15 years of age. Initially mistaken for common neonatal dermatitis, the condition proved to be complex, affecting Júlia’s skin, lymph nodes, liver, and spleen. Her family’s search for answers led them from Luís Eduardo Magalhães (BA) to Brasília, ultimately receiving a diagnosis at HCB.
A Multidisciplinary Approach to Care
HCB’s strategy for “rare children” extends beyond clinical treatment, encompassing an ecosystem that integrates cutting-edge laboratory support with comprehensive family care. The hospital provides multidisciplinary care, including access to dentistry, psychology, nutrition, and rehabilitation services, without requiring additional referrals. Recognizing the emotional impact of a rare disease diagnosis, HCB offers support from psychology and social services.
Translational Research and Personalized Treatment
HCB utilizes translational research to optimize therapeutic responses, bridging clinical practice with rigorous laboratory research. This approach aims to identify the root cause of a child’s condition, enabling personalized treatment plans and avoiding ineffective protocols. The hospital employs techniques ranging from PCR and flow cytometry to next-generation sequencing (NGS) for complex cases.
The Importance of Early Diagnosis and Genetic Counseling
Early diagnosis is crucial for consolidating specialized care for patients with rare diseases. The Federal District’s public health network offers one of the largest neonatal screening programs in the country, currently testing around 50 pathologies through heel prick tests, with plans for expansion. Genetic counseling is a mandatory component of the care flow, extending the diagnosis to the entire family to assess the risk of recurrence in future children.
Looking Ahead
The efforts of the Hospital da Criança de Brasília exemplify the importance of integrating various components of the Unified Health System (SUS) to improve outcomes for individuals with rare diseases. A focus on quality diagnosis, coordinated services, and active family participation are essential for enhancing the lives of those affected by these conditions.